ABcomm, Inc., with headquarters in Champaign, Illinois and Scottsdale, Arizona, has been involved in developing continuing education and training programs for health professionals since 1988.
Our primary focus is on accredited activities for physicians, pharmacists and nurse practitioners. ABcomm, Inc. is accredited by the American Council for Continuing Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Academy of Nurse Practitioners (AANP).
Dyslipidemia Minifellowship: Complex Cases, Comprehensive Management
October 4, 2008
This half-day minifellowship is designed to provide physicians with evidence-based information on current issues and management strategies in the treatment of dyslipidemia. Topics have been selected based on extensive needs assessment data in the treatment of Dyslipidemia, including past participant surveys, clinical expert input, and practice guideline reviews.
CME Sponsor: ABcomm, Inc.
Location: The
Course Directors/Instructors:
Thomas Bersot, MD
Kenneth Feingold, MD; Mikele McCoin, MPH, RD
Registration Fee: $30
Number of credits:
5.5 AMA PRA Category 1 Credits™
Registration:
By Fax: Fax
completed form to ABcomm at (217) 355 – 1469
By Phone:
Call ABcomm at (800) 451 - 4068
Detailed Description:
This
half-day minifellowship is designed to provide physicians with evidence-based
information on current issues and management strategies in the treatment of
dyslipidemia. Through a live patient
interview, lectures, case studies and open discussions, the small group format
facilitates interaction between attendees and local and national opinion
leaders.
The goal of this Minifellowship is to enhance the knowledge of providers resulting in improved patient care. Topics have been selected based on extensive needs assessment data in the treatment of Dyslipidemia, including past participant surveys, clinical expert input, and practice guideline reviews.
Learning Objectives:
- Outline cholesterol targets and describe why many patients are not treated to goal.
- Discuss the role of elevated triglycerides and low high-density lipoprotein cholesterol in the overall patient profile, considering the impact of multiple lipid risk factors in cardiovascular disease risk.
- Review the accepted guidelines for treating multiple lipid parameters.
- Determine treatment options for the longitudinal care of dyslipidemia patients, including patients with diabetes, the metabolic syndrome, and other concomitant disorders.
- Analyze risk profiles of various medications alone and in combination, focusing on safety, tolerability and side-effect management.
- Describe how engaging patients in their own treatment goals leads to healthier lifestyle choices and medication adherence.